SCHEMBL29801223

SCHEMBL29801223

c1ccc2c(-c3nsc4ccccc34)onc2c1

nearest known ligand 0.42

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
▸ ALDH1A1 P00352 6/20 0.42
▸ KDM4E B2RXH2 4/20 0.42
▸ HSD17B10 Q99714 3/20 0.42
▸ MAPT P10636 2/20 0.42
▸ EPAS1 Q99814 8/20 0.37
▸ HPGD P15428 2/20 0.34
▸ SMN1; SMN2 Q16637 1/20 0.34
▸ IP6K1 Q92551 3/20 0.32
▸ IP6K3 Q96PC2 2/20 0.32
▸ IP6K2 Q9UHH9 2/20 0.32
▸ MEN1 O00255 2/20 0.32
▸ KMT2A Q03164 2/20 0.32
▸ TP53 P04637 1/20 0.32
▸ NPC1 O15118 1/20 0.32
▸ POLB P06746 1/20 0.32
▸ EPHX2 P34913 1/20 0.31
▸ ADRA2A P08913 1/20 0.30
▸ FBP1 P09467 1/20 0.30
▸ ADORA3 P0DMS8 1/20 0.30
▸ DRD2 P14416 1/20 0.30

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL31001160 0.75 ALDH1A1 (0.46) ALDH1A1KDM4EHSD17B10MAPTHPGD
SCHEMBL30987223 0.75 MAPT (0.60) ALDH1A1KDM4EHSD17B10MAPTEPAS1
SCHEMBL28563540 0.75 MAPT (0.60) ALDH1A1KDM4EHSD17B10MAPTEPAS1
SCHEMBL6691319 0.70 ALDH1A1 (0.55) ALDH1A1KDM4EHSD17B10MAPTHPGD
SCHEMBL16563217 0.70 ALDH1A1 (0.30) ALDH1A1HPGDSMN1; SMN2
SCHEMBL2492556 0.69 ALDH1A1 (0.62) ALDH1A1KDM4EHSD17B10MAPTHPGD
SCHEMBL6964514 0.69 KDM4E (0.52) ALDH1A1KDM4EHSD17B10MAPTEPAS1
SCHEMBL19358934 0.67 KDM4E (0.46) ALDH1A1KDM4EHSD17B10MAPTEPAS1
SCHEMBL29633947 0.67 GPR3 (0.42) ALDH1A1KDM4EHSD17B10MAPTHPGD
SCHEMBL13700942 0.66 ELANE (0.58) ALDH1A1KDM4EMAPTHPGDSMN1; SMN2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
CN-109535155-B Apoptosis-inducing agents for the treatment of cancer and immune and autoimmune diseases 艾伯维公司 2022-07-12 — — CN disclosed
Send feedback